These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38719530)

  • 1. Deprescribing in older adults with polypharmacy.
    Hung A; Kim YH; Pavon JM
    BMJ; 2024 May; 385():e074892. PubMed ID: 38719530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial.
    Bayliss EA; Shetterly SM; Drace ML; Norton J; Green AR; Reeve E; Weffald LA; Wright L; Maciejewski ML; Sheehan OC; Wolff JL; Gleason KS; Kraus C; Maiyani M; Du Vall M; Boyd CM
    Trials; 2020 Jun; 21(1):542. PubMed ID: 32552857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy.
    Omuya H; Nickel C; Wilson P; Chewning B
    Int J Pharm Pract; 2023 Jun; 31(4):349-368. PubMed ID: 37155330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.
    Ulley J; Harrop D; Ali A; Alton S; Fowler Davis S
    BMC Geriatr; 2019 Jan; 19(1):15. PubMed ID: 30658576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Deprescribing Practices and the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions Criteria to Reduce Harm and Preventable Adverse Drug Events in Older Adults.
    Earl TR; Katapodis ND; Schneiderman SR; Shoemaker-Hunt SJ
    J Patient Saf; 2020 Sep; 16(3S Suppl 1):S23-S35. PubMed ID: 32809998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis.
    Carollo M; Crisafulli S; Vitturi G; Besco M; Hinek D; Sartorio A; Tanara V; Spadacini G; Selleri M; Zanconato V; Fava C; Minuz P; Zamboni M; Trifirò G
    J Am Geriatr Soc; 2024 Oct; 72(10):3219-3238. PubMed ID: 38822740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of deprescribing in older adults with dementia: a narrative review.
    Sawan MJ; Moga DC; Ma MJ; Ng JC; Johnell K; Gnjidic D
    Expert Rev Clin Pharmacol; 2021 Nov; 14(11):1367-1382. PubMed ID: 34311630
    [No Abstract]   [Full Text] [Related]  

  • 8. Family conferences and shared prioritisation to improve patient safety in the frail elderly (COFRAIL): study protocol of a cluster randomised intervention trial in primary care.
    Mortsiefer A; Wilm S; Santos S; Löscher S; Wollny A; Drewelow E; Ritzke M; Thürmann P; Mann NK; Meyer G; Abraham J; Icks A; Montalbo J; Wiese B; Altiner A;
    Trials; 2020 Mar; 21(1):285. PubMed ID: 32197631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial.
    McDonald EG; Wu PE; Rashidi B; Wilson MG; Bortolussi-Courval É; Atique A; Battu K; Bonnici A; Elsayed S; Wilson AG; Papillon-Ferland L; Pilote L; Porter S; Murphy J; Ross SB; Shiu J; Tamblyn R; Whitty R; Xu J; Fabreau G; Haddad T; Palepu A; Khan N; McAlister FA; Downar J; Huang AR; MacMillan TE; Cavalcanti RB; Lee TC
    JAMA Intern Med; 2022 Mar; 182(3):265-273. PubMed ID: 35040926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advancing the Science of Deprescribing: A Novel Comprehensive Conceptual Framework.
    Linsky A; Gellad WF; Linder JA; Friedberg MW
    J Am Geriatr Soc; 2019 Oct; 67(10):2018-2022. PubMed ID: 31430394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta-analysis.
    Quek HW; Page A; Lee K; Lee G; Hawthorne D; Clifford R; Potter K; Etherton-Beer C
    Br J Clin Pharmacol; 2024 Oct; 90(10):2409-2482. PubMed ID: 39164070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing Interventions for Older Patients: A Systematic Review and Meta-Analysis.
    Zhou D; Chen Z; Tian F
    J Am Med Dir Assoc; 2023 Nov; 24(11):1718-1725. PubMed ID: 37582482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of the evidence for deprescribing interventions among older people living with frailty.
    Ibrahim K; Cox NJ; Stevenson JM; Lim S; Fraser SDS; Roberts HC
    BMC Geriatr; 2021 Apr; 21(1):258. PubMed ID: 33865310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family Conferences to Facilitate Deprescribing in Older Outpatients With Frailty and With Polypharmacy: The COFRAIL Cluster Randomized Trial.
    Mortsiefer A; Löscher S; Pashutina Y; Santos S; Altiner A; Drewelow E; Ritzke M; Wollny A; Thürmann P; Bencheva V; Gogolin M; Meyer G; Abraham J; Fleischer S; Icks A; Montalbo J; Wiese B; Wilm S; Feldmeier G
    JAMA Netw Open; 2023 Mar; 6(3):e234723. PubMed ID: 36972052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation considerations of deprescribing interventions: A scoping review.
    Wang J; Shen JY; Conwell Y; Podsiadly EJ; Caprio TV; Nathan K; Yu F; Ramsdale EE; Fick DM; Mixon AS; Simmons SF
    J Intern Med; 2024 Apr; 295(4):436-507. PubMed ID: 36524602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing in Advanced Illness: Aligning Patient, Clinician, and Health Plan Goals.
    Parekh N; Schenker Y; Good CB; Neilson L; Shrank WH
    J Gen Intern Med; 2019 Apr; 34(4):631-633. PubMed ID: 30719644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deprescribing for Community-Dwelling Older Adults: a Systematic Review and Meta-analysis.
    Bloomfield HE; Greer N; Linsky AM; Bolduc J; Naidl T; Vardeny O; MacDonald R; McKenzie L; Wilt TJ
    J Gen Intern Med; 2020 Nov; 35(11):3323-3332. PubMed ID: 32820421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing: An umbrella review.
    Japelj N; Horvat N; Knez L; Kos M
    Acta Pharm; 2024 Jun; 74(2):249-267. PubMed ID: 38815201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
    Ailabouni N; Mangin D; Nishtala PS
    Int J Clin Pharm; 2019 Feb; 41(1):167-178. PubMed ID: 30659492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified delphi process.
    Farrell B; Tsang C; Raman-Wilms L; Irving H; Conklin J; Pottie K
    PLoS One; 2015; 10(4):e0122246. PubMed ID: 25849568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.